The future of neoantigen research holds significant promise for advancing cancer treatment. Ongoing research aims to improve the accuracy and speed of neoantigen identification and to develop more robust and scalable methods for neoantigen-based therapies. With advancements in artificial intelligence and machine learning, predictive models are becoming more precise, potentially leading to more effective and personalized cancer treatments.
